2024 Annual Report
2024 was a pivotal year for AdvaMed, the medtech association, championing our member companies’ remarkable technologies and the patients they serve. From robust advocacy to events convening thought leaders, from navigating complex FDA and CMS processes to enhancing public affairs work, our dedication to promoting lifesaving, life-enhancing medtech for all patients led to numerous achievements and significant advancements. Here are just a few examples:
Fully Integrated AdvaMed’s Medical Imaging and Digital Health Tech Divisions
The establishment of these two divisions cemented AdvaMed’s representation of the entire medtech spectrum.
Protected Sterilization Capacity for Patient Access to Lifesaving Medtech
AdvaMed engaged with EPA, FDA, doctor and patient groups, and hospitals to ensure EPA’s updated regulation of the sterilization process would be workable, protecting both the supply of critical medtech and the communities surrounding sterilization facilities.
Supported FDA’s Regulation of Lab-Developed Tests (LDTs)
The final LDT rule issued by FDA ensures diagnostic tests, regardless of where they were developed, meet FDA’s rigorous standards for safety and effectiveness.
Protected Medtech from State and Federal “Right to Repair” Laws
Unauthorized repairs of complex medical technologies can render them dangerous to patients. Exempting medtech from state legislation and keeping the language out of federal legislation is critical to ensuring patient safety.
Achieved Record Attendance at The MedTech Conference
Toronto welcomed 4,350 attendees from 48 countries, with record participation across AI, digital health, cybersecurity, and more from medtech leaders, investors, and member companies.
Boosted Membership
AdvaMed’s growing membership now includes more than 600 companies, strengthening the organization’s voice and impact in our advocacy work promoting access to life-changing, lifesaving medtech.
Secured Expedited Medicare Coverage Pathway for Breakthrough Technologies
After years of AdvaMed advocacy, CMS instituted a new policy to expedite Medicare coverage of certain FDA-designated breakthrough medical technologies. While the new policy is a good start, AdvaMed continues to push Congress to expand Medicare’s breakthrough coverage to benefit more patients in need.
Multiple Payment and Reimbursement Policy Wins
Our advocacy led to several favorable coding, coverage, and payment wins for AdvaMed member companies and the patients who rely on our technologies. For example, CMS finalized separate payment for radiopharmaceuticals related to PET scans.
Expanded CMS Coverage for Digital Mental Health Technologies
A new AdvaMed-backed CMS rule extended coverage to a subset of digital therapeutics, an important step in improving patient access to these treatments.
Earned Accreditation to Develop Industry Standards
The American National Standards Institute’s (ANSI) accreditation is a stamp of approval of AdvaMed’s credibility and reliability, and positions AdvaMed as a trusted leader in AI, cybersecurity, and imaging.
Showcased Medtech Innovation on Capitol Hill
June’s Medtech Showcase spotlighted groundbreaking medical and health technologies that are shaping the future of health care, drawing more than 250 Hill staff and lawmakers.
50 Years of Transforming Lives
Join AdvaMed as we celebrate 50 years of innovation, leadership, and shaping the future of health care together.
Download the Report
About AdvaMed
AdvaMed, the Medtech Association, is the world’s largest trade organization representing medtech innovators. Our member companies develop, manufacture, and distribute the technologies including devices, equipment, diagnostic tests, and imaging technology that are transforming health care through earlier disease detection, less invasive procedures, and more effective treatments. Based in Washington, D.C., AdvaMed has more than 600 members, operating all over the United States and world.
Our divisions are AdvaMedDx, for diagnostics companies; Accel, for emerging and early-stage companies; Digital Health Tech; and Medical Imaging. Our sectors are Radiation Therapy, Diabetes, and Orthopedic.
AdvaMed member companies serve the entire health care ecosystem with their products, from general medicine to every medical field and specialty: orthopedics, maternal health, neurology, ophthalmology, urology, gastroenterology, and much more.
Our organization advocates for increased patient access to safe, effective, lifesaving, and life-enhancing medtech. This advocacy unfolds in the halls of the U.S. Congress, with federal agencies, at the White House, and in every state legislature.
AdvaMed conducts its work through our main board of directors, boards for each division, and dozens of working groups on specialized topics. Company representatives interact with our advocacy and technology and regulatory expert staffs to convey the impact of policies on patients to policymakers and regulators. Together, we press for policies that promote access to medtech to every patient who could benefit from it.
Scott Whitaker, President and CEO, AdvaMed“Access to medical technology is critical to improving the well-being of patients, and we will advocate for the policies we developed with patient groups to meet these needs. We look forward to working with our partners and state policymakers to secure adoption of these patient-focused proposals.”
Peter J. Arduini, President and CEO of GE HealthCare and Chair of the AdvaMed Board of Directors“We are in a new era in which medical imaging is ubiquitous—an era in which providers rely on imaging for screening, diagnosis, monitoring, and therapy delivery, as well as medical research and discovery.”
Patrick Hope, Executive Director, AdvaMed Medical Imaging“The medical imaging division is leading the way to advance the industry through advocacy and standards development that consistently improve patient outcomes turning more patients into survivors.”
DeChane Dorsey, Executive Director, AdvaMed Accel“Our AdvaMed Accel members are on the verge of some of the most promising medical breakthroughs – and they depend on AdvaMed Accel to help them take their ideas from inception to market.”